Monogram Technologies (NASDAQ ... were $2.4 million compared to $1.9 million in the prior year period. The R&D increase was primarily due to the company moving into the verification and validation ...

Receives FDA Clearance for the mBôsTM TKA System Groundbreaking Trial Set to Deliver one of the World's First Autonomous Saw-Based Robotic ...

with R.F. Lafferty as syndicate manager. Selling group members included Cambria Capital, DealMaker Securities and OpenDeal Broker. Based in Austin, Texas, Monogram is a developer of orthopedic ...

MGRM READ THE FULL MGRM RESEARCH REPORT Monogram (NASDAQ:MGRM) reported 1 st quarter 2025 financial results on May 14, 2025 which were largely in line with our expectations. Research and development ...